Wakefield J, Walker S
Department of Epidemiology and Public Health, Imperial College School of Medicine at St. Mary's, London, UK.
Stat Med. 1997 May 30;16(10):1135-49. doi: 10.1002/(sici)1097-0258(19970530)16:10<1135::aid-sim517>3.0.co;2-6.
Before a drug can be marketed, an initial dose must be established. Sheiner et al. argue that a population approach leads to the most informed and rational decision making. We discuss the choice of an initial dose from both a predictive and estimative viewpoint. Our criteria are based upon evaluating the probabilities that a patient from the specified population obtains a response that is at least of a specified size. We demonstrate the approach using a simulation study and compare estimation of population parameters and initial dose using Bayesian and likelihood-based methods.
在一种药物能够上市之前,必须确定初始剂量。谢纳等人认为,群体方法能带来最明智且合理的决策。我们从预测和估计的角度讨论初始剂量的选择。我们的标准基于评估特定群体中的患者获得至少特定规模反应的概率。我们通过模拟研究展示该方法,并使用贝叶斯方法和基于似然性的方法比较群体参数估计和初始剂量。